Debut Plus

1,790

-20.46 -1.13%

10 Sept 2026

NSE Listed

LT-ASM · ASM 1
What does LT-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-08-18
NSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-08-19

Rubicon Research Limited (RUBICON)

Volume: 1,43,377Avg Vol 1W: 1,69,295.2Avg Vol 1M: 4,62,833.652W Range:570.751,899
Key Ratios
Checked 3h ago
Market Cap₹29,630 Cr
Current Price₹1,790
Previous Close₹1,810.46
High / Low (52w)₹1,899 / ₹570.75
Volume1,43,377
Avg Vol (1W)1,69,295.2
Avg Vol (1M)4,62,833.6
Stock P/E102.81
Book Value₹77.86
Dividend Yield8%
ROE19.14%
ROA12.39%
Revenue (TTM)₹1,762 Cr
Revenue Growth50.4%
Profit Margin14.89%
Total Debt₹64 Cr
Shares Outstanding17 Cr
Face Value₹1
EPS (TTM)₹17.41
P/B22.99
Debt / Equity0.4
50 DMA₹1,613.43
200 DMA₹1,067.52
Day change-1.13%
SurveillanceLT-ASM · ASM 1
Price Chart
1,790 184.94% · 1Y
18615772.5Cr
2025-10-16
2026-09-10

20-day avg volume: 4.6L shares

Pros
  • Healthy return on equity of 19.1%.
  • Pays a dividend yield of 8.0%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Revenue fell 13% YoY.
  • Stock trades at a high P/E of 103.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹296 Cr₹313 Cr₹358 Cr₹352 Cr₹412 Cr₹476 Cr₹514 Cr₹534 Cr
EBITDA₹56 Cr₹61 Cr₹63 Cr₹70 Cr₹83 Cr₹100 Cr₹109 Cr₹120 Cr
Net Profit₹34 Cr₹38 Cr₹36 Cr₹43 Cr₹54 Cr₹73 Cr₹77 Cr₹85 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹1,288 Cr₹301 Cr₹278 Cr₹336 Cr₹302 Cr₹390 Cr₹1,762 Cr₹428 Cr
EBITDA₹231 Cr₹65 Cr₹56 Cr₹71 Cr₹57 Cr₹100 Cr₹363 Cr₹117 Cr
Net Profit₹134 Cr₹40 Cr₹35 Cr₹46 Cr₹37 Cr₹70 Cr₹247 Cr₹82 Cr
EPS8.6815.31
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹430 Cr₹538 Cr₹560 Cr₹750 Cr₹1,109 Cr₹1,451 Cr₹2,327 Cr
Total Liabilities₹90 Cr₹164 Cr₹254 Cr₹463 Cr₹724 Cr₹910 Cr₹1,038 Cr
Equity₹341 Cr₹374 Cr₹305 Cr₹286 Cr₹385 Cr₹541 Cr₹1,289 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹32 Cr₹95 Cr₹-54 Cr₹-73 Cr₹39 Cr₹198 Cr₹314 Cr
Investing₹-84 Cr₹-46 Cr₹-55 Cr₹-34 Cr₹-69 Cr₹-65 Cr₹-410 Cr
Financing₹80 Cr₹52 Cr₹63 Cr₹123 Cr₹44 Cr₹-40 Cr₹283 Cr
Free Cash Flow₹-27 Cr₹24 Cr₹-109 Cr₹-117 Cr₹-17 Cr₹198 Cr₹314 Cr
Shareholding
Promoter 59.76% Institutions 16.95% Public 23.3%
Efficiency & Working Capital
ROCE22.6%
Interest Coverage8.6
Dividend Payout
Debtor Days106 d
Inventory Days152 d
Payable Days79 d
Cash Conversion Cycle179 d
Working Capital Days258 d
Shareholding Details

As of 2026-06-30

Promoter59.8%
FII7.5%
DII9.4%
Institutions16.9%
Public23.3%
Promoter Pledge0%
No. of Shareholders43,254
Shareholding Pattern

Quarterly — figures in %. Latest 8 quarters.

PeriodJul 2024Jul 2024Sept 2025Oct 2025Oct 2025Dec 2025Mar 2026Jun 2026
Promoters84.2%84.2%60%60%60%60%59.9%59.8%
FIIs0%0%9.4%5.4%9.4%8%7.5%7.5%
DIIs15.8%0%10.5%10.5%10.5%9.4%10%9.4%
Public0%15.8%20.1%24.1%20.1%22.6%22.6%23.3%
Promoter Pledge0%0%0%0%0%0%0%0%
No. of Shareholders15151,05,3111,05,3111,05,31131,91433,73843,254
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
General Atlantic Singapore Rr Pte LtdShareholding of Promoter and Promoter Group35.8%5.93 Cr
Shivanand Shankar Mankekar HufPublic Shareholding13.5%2.24 Cr
Surabhi Parag SanchetiShareholding of Promoter and Promoter Group7.9%1.31 Cr
Sumant PilgaonkarShareholding of Promoter and Promoter Group7.9%1.31 Cr
Pratibha Sudhir PilgaonkarShareholding of Promoter and Promoter Group3.9%64,35,000
Sudhir D PilgaonkarShareholding of Promoter and Promoter Group3.9%64,35,000
Amansa Investments LtdPublic Shareholding3.1%51,60,278
Kotak Midcap FundPublic Shareholding2.9%47,11,435
Motilal Oswal Small Cap FundPublic Shareholding1.7%28,61,358
Fidelity Funds - India Focus FundPublic Shareholding1.4%23,50,854
Nomura Funds Ireland Public Limited Company- Nomura Funds Ireland - India Equity FundPublic Shareholding1.4%22,39,895
Bajaj Finserv Flexi Cap FundPublic Shareholding1.3%21,91,575
Narendra Narhar BorkarPublic Shareholding1.1%17,63,790
Terentia Venture PartnersShareholding of Promoter and Promoter Group0.3%5,10,000
Parag Suganchand SanchetiShareholding of Promoter and Promoter Group0%30,000
Prashant PilgaonkarShareholding of Promoter and Promoter Group0%0
Sheela Suganchand SanchetiShareholding of Promoter and Promoter Group0%0
Suganchand Gendulal SanchetiShareholding of Promoter and Promoter Group0%0
Ananya Parag SanchetiShareholding of Promoter and Promoter Group0%0
Ira Parag SanchetiShareholding of Promoter and Promoter Group0%0
Saloni PilgaonkarShareholding of Promoter and Promoter Group0%0
Kimaya Sumant PilgaonkarShareholding of Promoter and Promoter Group0%0
Kirit Vishanji GalaShareholding of Promoter and Promoter Group0%0
Rumie GalaShareholding of Promoter and Promoter Group0%0
Smeet GalaShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
CHANGAVALLI VENKATChairman & Independent Directo2025
PRATIBHA SUDHIR PILGAONKARExecutive Director & MD2025
PARAG SUGANCHAND SANCHETIExecutive Director & CEO2025
Varun TalukdarNon Executive Director2025
Shantanu RastogiNon Executive Director2025
Anand AgarwalNon Executive Director2025
K G AnanthakrishnanIndependent Non Exe. Director2025
MILIND ANIL PATILIndependent Non Exe. Director2025
DEEPASHREE OMKAR TANKSALECompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Service₹22 Cr14.3%
Manufacturing₹132 Cr85.7%
In-house Reseach & Development₹0 Cr0%
Segments — Geography
RegionRevenueShare
India₹11 Cr1.3%
USA₹832 Cr97.4%
Others₹11 Cr1.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1241717
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-14Board Meetings
forthcoming2026-08-07Dividend (1.5/- per share)Final
dividend2026-08-07₹1.5 (150%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20262,265001272,290
202682000088
20261,149001271,168
Insider / Designated-Person Trades

27 recent disclosure(s)

Vinayak SawantDisposal · 1,100
General Atlantic Singapore RR Pte LtdDisposal · 1,38,53,073
General Atlantic Singapore RR Pte LtdDisposal · 1,46,927
Sanjay RenapurkarDisposal · 2,000
Sanjay RenapurkarDisposal · 4,000
Sarabjit SinghDisposal · 35,000
Company Information
Incorporated1999
ChairmanCHANGAVALLI VENKAT
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
🌐 www.rubicon.co.in

📍 Medone House B-75 Road No.33, Wagle Estate, Thane (West), Maharashtra, 400604

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search